A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jethro Hu, MD
Cedars-Sinai Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
Chirag Patil, MDGillian Gresham, PhDJeremy Rudnick, MDJohn Yu, MDLJ Amaral, MS, RD, CSOMourad Tighiouart, PhDRay Chu, MDStephen Freedland, MDSungyong You, PhDRecruiting - University of California, San Francisco
San Francisco, California, United States
Recruiting - Pacific Neuroscience Institute / Saint John'S Cancer Institute
Santa Monica, California, United States
Recruiting - Duke University
Durham, North Carolina, United States
Jen-Tsan Chi, MD, PhDLin Pao-Hwa, PhDRecruiting - Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Withdrawn
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jun 2023
- Primary completion
- 30 Sept 2028
- Completion
- 30 Sept 2029
- Last update posted
- 6 May 2026
- Registered enrollment
- 170
- Registry id
- NCT05708352
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.